765 related articles for article (PubMed ID: 9653017)
1. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
2. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
3. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
O'Brien BA; Harmon BV; Cameron DP; Allan DJ
J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
[TBL] [Abstract][Full Text] [Related]
5. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose.
Wang Z; Gleichmann H
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260
[TBL] [Abstract][Full Text] [Related]
6. Insulin and GLUT2 glucose transporter immunoreactivity in B-cells of whole pancreas isografts and allografts in the streptozotocin-diabetic rat.
Jörns A; Klempnauer J
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():103-6. PubMed ID: 8839264
[TBL] [Abstract][Full Text] [Related]
7. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
8. Did the gradual loss of GLUT2 cause a shift to diabetic disorders in the New Zealand obese mouse (NZO/Hl)?
Chankiewitz E; Peschke D; Herberg L; Bazwinsky I; Mühlbauer E; Brömme HJ; Peschke E
Exp Clin Endocrinol Diabetes; 2006 May; 114(5):262-9. PubMed ID: 16804801
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates.
Martin S; Hibino T; Faust A; Kleemann R; Kolb H
J Autoimmun; 1996 Oct; 9(5):637-43. PubMed ID: 8933279
[TBL] [Abstract][Full Text] [Related]
10. Study on pancreatic lymphatics in nonobese diabetic mouse with prevention of insulitis and diabetes by adjuvant immunotherapy.
Qu P; Ji RC; Shimoda H; Miura M; Kato S
Anat Rec A Discov Mol Cell Evol Biol; 2004 Dec; 281(2):1326-36. PubMed ID: 15386276
[TBL] [Abstract][Full Text] [Related]
11. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
12. Detrimental effect of protracted hyperglycaemia on beta-cell neogenesis in a mouse murine model of diabetes.
Guz Y; Torres A; Teitelman G
Diabetologia; 2002 Dec; 45(12):1689-96. PubMed ID: 12488958
[TBL] [Abstract][Full Text] [Related]
13. Lazaroid antioxidant reduces incidence of diabetes and insulitis in nonobese diabetic mice.
Rabinovitch A; Suarez WL; Power RF
J Lab Clin Med; 1993 Apr; 121(4):603-7. PubMed ID: 8454942
[TBL] [Abstract][Full Text] [Related]
14. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
15. Development of insulitis and diabetes in B cell-deficient NOD mice.
Yang M; Charlton B; Gautam AM
J Autoimmun; 1997 Jun; 10(3):257-60. PubMed ID: 9218752
[TBL] [Abstract][Full Text] [Related]
16. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
Hosokawa M; Dolci W; Thorens B
Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse.
Dahlén E; Dawe K; Ohlsson L; Hedlund G
J Immunol; 1998 Apr; 160(7):3585-93. PubMed ID: 9531322
[TBL] [Abstract][Full Text] [Related]
18. Effect of prophylactic insulin treatment on the number of ER-MP23+ macrophages in the pancreas of NOD mice. Is the prevention of diabetes based on beta-cell rest?
Jansen A; Rosmalen JG; Homo-Delarche F; Dardenne M; Drexhage HA
J Autoimmun; 1996 Jun; 9(3):341-8. PubMed ID: 8816969
[TBL] [Abstract][Full Text] [Related]
19. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
20. Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice.
Choi MS; Jung UJ; Yeo J; Kim MJ; Lee MK
Diabetes Metab Res Rev; 2008; 24(1):74-81. PubMed ID: 17932873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
